Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer
Acquisition of mesenchymal properties by cancer cells is a critical event for the development of malignancy. Here, the authors show that in renal cancer cells, lysosphosphatidic acid does not utilize the RhoA pathway but specifically activates the Arf6 mesenchymal pathway via its GPCRs and EFA6 to p...
Guardado en:
Autores principales: | Shigeru Hashimoto, Shuji Mikami, Hirokazu Sugino, Ayumu Yoshikawa, Ari Hashimoto, Yasuhito Onodera, Shotaro Furukawa, Haruka Handa, Tsukasa Oikawa, Yasunori Okada, Mototsugu Oya, Hisataka Sabe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df5d72ff58b24394a6c880e7d14b9eab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Arf6-driven cell invasion is intrinsically linked to TRAK1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe
por: Yasuhito Onodera, et al.
Publicado: (2018) -
Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX
por: Mei Horikawa, et al.
Publicado: (2022) -
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Keiko Fukasawa, et al.
Publicado: (2021) -
Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways
por: Hiroshi Hongo, et al.
Publicado: (2021) -
Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
por: Willem-Jan Keune, et al.
Publicado: (2016)